The Potential Economic Value of a Trypanosoma cruzi (Chagas Disease) Vaccine in Latin America

Abstract

Results indicate that a T. cruzi vaccine could provide substantial economic benefit, depending on the cost of the vaccine, and support continued efforts to develop a human vaccine.